0001474064-13-000025.txt : 20130211
0001474064-13-000025.hdr.sgml : 20130211
20130211164400
ACCESSION NUMBER: 0001474064-13-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130207
FILED AS OF DATE: 20130211
DATE AS OF CHANGE: 20130211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Selisker Rachel R
CENTRAL INDEX KEY: 0001313793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 13592314
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-02-07
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001313793
Selisker Rachel R
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Common stock
2013-02-07
4
J
0
15225
A
15225
D
Common stock
2013-02-07
4
S
0
5325
8.74
D
9900
D
Shares acquired upon vesting of restricted stock units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012.
The Reporting Person reported all restricted stock units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2012.
/s/ Edward Stratemeier as Attorney-in-Fact
2013-02-11